Alzheon researchers discover key Alzheimer's substance
Worcester Business Journal,
Photo/Google Alzheon headquarters in Framingham. The company is working on a drug to treat Alzheimer's.
Photo/Google Alzheon headquarters in Framingham. The company is working on a drug to treat Alzheimer's.
3-D Rendering of beta-amyloid peptide, a hallmark pathology in Alzheimer's disease Scientists with Framingham, Massachusetts-base…
FRAMINGHAM, Mass.--(Business Wire)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new…
FRAMINGHAM, Mass.--( BUSINESS WIRE )-- Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new…